AJP - Gastrointestinal and Liver Physiology, Vol 269, Issue 5 745-G753, Copyright © 1995 by American Physiological Society

ARTICLES

Change in hepatic handling of hepatocyte growth factor during liver regeneration in rats

K. X. Liu, Y. Kato, T. Terasaki, T. Nakamura and Y. Sugiyama
Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.

The change in the hepatic uptake clearance of hepatocyte growth factor (HGF) during liver regeneration in rats was examined. The hepatic uptake clearance per gram liver of 125I-labeled HGF in vivo decreased to a minimum level only 15 min after partial hepatectomy (PH). In the perfused liver, in which the effect of endogenous substances can be ignored, the hepatic uptake clearance of 125I-HGF did not change until at least 3 h after PH, suggesting that the decrease in the clearance in vivo is caused by some endogenous inhibitors. Such a decrease in the clearance cannot be explained only by the elevated endogenous HGF concentration in plasma. In addition, at 48 h after PH the decrease in hepatic uptake clearance was comparable for in vivo and perfused liver (approximately 50 and 60% reduction, respectively), suggesting that the decreased hepatic clearance in vivo at that time was caused mainly by reduction in the binding and/or uptake by the liver itself. In addition, the hepatic uptake clearance of 125I-HGF at that time in the presence of an excess (135 pM) of unlabeled HGF was comparable with that of the control, indicating that only the saturable portion of hepatic uptake clearance is reduced. The internalization rate constant representing the probability of cell surface-bound 125I-HGF being internalized per unit time increased to three times that of the control at 15 min after PH, demonstrating that the internalization of HGF is enhanced immediately after the start of liver regeneration.

This article has been cited by other articles:

				M. Kato, Y. Kato, T. Nakamura, and Y. Sugiyama Efficient Extraction by the Liver Governs Overall Elimination of Hepatocyte Growth Factor in Rats J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 373 - 379. [Abstract] [Full Text]

				K.-X. Liu, Y. Kato, I. Kino, T. Nakamura, and Y. Sugiyama Ligand-induced downregulation of receptor-mediated clearance of hepatocyte growth factor in rats Am J Physiol Endocrinol Metab, November 1, 1998; 275(5): E835 - E842. [Abstract] [Full Text] [PDF]

				K.-X. Liu, Y. Kato, T.-I. Kaku, K. Matsumoto, T. Nakamura, and Y. Sugiyama Protamine enhances the proliferative activity of hepatocyte growth factor in rats Am J Physiol Gastrointest Liver Physiol, January 1, 1998; 274(1): G21 - G28. [Abstract] [Full Text] [PDF]

				K.-X. Liu, Y. Kato, M. Kato, T.-I. Kaku, T. Nakamura, and Y. Sugiyama Existence of two nonlinear elimination mechanisms for hepatocyte growth factor in rats Am J Physiol Endocrinol Metab, November 1, 1997; 273(5): E891 - E897. [Abstract] [Full Text] [PDF]

				Y. Mano, H. Suzuki, T. Terasaki, T. Iwahashi, K.-I. Ono, M. Naito, T. Tsuruo, and Y. Sugiyama Kinetic Analysis of the Disposition of MRK16, an Anti-P-glycoprotein Monoclonal Antibody, in Tumors: Comparison Between in Vitro and in Vivo Disposition J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 391 - 401. [Abstract] [Full Text]